Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.7%

1 terminated out of 15 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

20%

3 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

89% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (5)
P 1 (2)
P 2 (1)
P 3 (2)
P 4 (1)

Trial Status

Completed8
Unknown5
Withdrawn1
Terminated1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (15)

Research Network

Activity Timeline